ConductScience.org, home

Trial · NCT07896993

Mask Instant Clinical Study

NCT07896993, Not applicable, Completed, ChinaNorm

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Mask Instant Clinical Study. Trials, record NCT07896993. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896993

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Mask Instant Clinical Study
NCT number
NCT07896993
Status
Completed
Phases
Not applicable
Enrollment
35 participants, actual
Lead sponsor
ChinaNorm
Conditions
Skin Barrier Function, Skin Soothing Effect
Interventions
Test soothing facial mask
First posted
2026-10-27
Last updated
2026-10-27

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryErythema index measured by Mexameter MX18BL (before infrared induction), T0 (immediately after induction), 10 minutes, 1 hour and 2 hours after inductionSkin erythema index of the hemiface will be measured by Mexameter MX18. Three consecutive valid readings will be taken and averaged for each measurement.
SecondaryDermatologist clinical assessment of skin rednessBL (before infrared induction), T0 (immediately after induction), 10 minutes, 1 hour and 2 hours after induction
Dermatologists perform clinical assessment of skin redness using modified Griffiths 10-point scale (0-9, half-point increments allowed). Whenever possible, the same dermatologist assesses the same participant; the rater is not permitted to refer to previous scores for post-baseline evaluations.
SecondaryVISIA-CR facial photographyBL (before infrared induction), T0 (immediately after induction), 10 minutes, 1 hour and 2 hours after inductionStandardized facial images (front, left, right) are captured under 4 lighting modes including standard light 1, standard light 2, cross polarized and parallel polarized light.
SecondaryTiVi700 measurement of skin microcirculationBL (before infrared induction), T0 (immediately after induction), 10 minutes, 1 hour and 2 hours after inductionTiVi700 captures skin microvascular red blood cell concentration (TiVi index) on bilateral cheek regions to assess cutaneous microcirculation status.
SecondarySubject self-assessment questionnaire for skin sensory symptoms10 minutes, 1 hour and 2 hours after infrared inductionSubjects self-grade stinging, itching, burning and tightness on a 0-4 intensity scale. Score 0 = none; Score 1 = very slight; Score 2 = slight; Score3 = moderate; Score4 = severe.
OtherFacial skin temperature measured by FLUKE TiS60+ infrared thermal cameraBL (before infrared induction), T0 (immediately after induction), 10 seconds, 1 minute and 5 minutes after inductionInfrared thermal facial photos are captured to record hemiface skin temperature by trained technicians.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07896993

GET https://conductscience.org/api/trials/v1/NCT07896993/registered